A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

The drug contributes to a higher percentage of body-mass weight loss compared to previous weight-loss medications, and accomplishes this more quickly.

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a year, according to a Cleveland Clinic study published Friday.

Ozempic and Wegovy are similar drugs that contain the same active ingredient, semaglutide, though Wegovy contains a higher amount of it and is FDA-approved specifically for weight loss.

Fact checked by Jennifer Klump People who use Wegovy for weight management may be at higher risk for hair loss, according to a preprint study. Researchers found that people prescribed semaglutide ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications ...

Topline Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year lost more weight than their male counterparts—but also experienced more nausea ...

In a head-to-head study in the New England Journal of Medicine, people taking Zepbound, Wegovy, Zepbound led to greater weight loss.

Using a random sample of 16 million patients, researchers found that women who newly initiated semaglutide (Ozempic, Wegovy) had a twofold higher risk of hair loss than those starting on the ...